Please find enclosed the Management Update on Audited Standalone & Consolidated Financial Results for the Fourth Quarter and Year ended March 31, 2026

Mgmt Guided Margin PressurePromoter Disclosed Acquisition PlansInvestor Communications View source PDF

VIRINCHI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-8.4%1-day move

₹17.29

prior close

₹16.43

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.0+0.0+0.0+0.0-8.4-9.3-13.1-11.4-10.9-13.5-2.5-5.1——

Up moveDown movePending

AI summary

Virinchi Ltd reported standalone Q4FY26 revenue of Rs. 44.45 Cr (up 16.55% YoY) but posted a PAT loss of Rs. 8.10 Cr due to a one-time bad-debt write-off of Rs. 8.43 Cr from QC Holdings receivable. Full-year standalone revenue grew 19.53% to Rs. 183.38 Cr with PAT of Rs. 13.98 Cr. Consolidated Q4FY26 showed revenue of Rs. 67.31 Cr and a PAT loss of Rs. 15.69 Cr, while FY26 consolidated revenue was Rs. 286.13 Cr with a PAT loss of Rs. 27.39 Cr. SaaS business drove growth with 15.42% revenue increase to Rs. 153.94 Cr, adding stable clients Check 'n Go and MoneyTree. IDC & IT Services revenue declined 29.55% to Rs. 40.37 Cr due to stricter US visa regime shifting work offshore. Healthcare revenue fell 23.20% to Rs. 79.99 Cr but EBIT turned positive at Rs. 0.15 Cr. The promoter infused capital into the healthcare subsidiary, acquiring a 49% stake.

Likely market impact

The stock faces short-term pressure from large Q4 losses and full-year consolidated losses, but underlying SaaS business remains strong with recurring revenue. The IDC segment faces structural margin pressure from visa restrictions, while healthcare turnaround is in early stages.